Total genes: 6823
| Gene | % of observations | # of cell lines | EV databases | Gene description | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Tissue1 | uSP | uEV-P20 | uEV-P150 | WCL | cEV-P20 | cEV-P150 | EVpedia2 | Exocarta3 | ||
| AHCTF1 | 5 | Protein ELYS | ||||||||
| AHCY | 2 | 5 | Adenosylhomocysteinase | |||||||
| AHCYL1 | 5 | 4 | Putative adenosylhomocysteinase 2 | |||||||
| AHCYL2 | 5 | 3 | Putative adenosylhomocysteinase 3 | |||||||
| AHNAK | 5 | 1 | 2 | Neuroblast differentiation-associated protein AHNAK | ||||||
| AHSA1 | 2 | 5 | 2 | Activator of 90 kDa heat shock protein ATPase homolog 1 | ||||||
| AHSG | Alpha-2-HS-glycoprotein | |||||||||
| AIDA | 3 | 1 | 3 | Axin interactor, dorsalization-associated protein | ||||||
| AIF1L | 5 | Allograft inflammatory factor 1-like | ||||||||
| AIFM1 | 5 | 5 | 4 | Apoptosis-inducing factor 1, mitochondrial | ||||||
| AIG1 | Androgen-induced gene 1 protein | |||||||||
| AIM1 | 5 | 1 | Absent in melanoma 1 protein | |||||||
| AIMP1 | 5 | 1 | Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 | |||||||
| AIMP2 | 1 | 5 | Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 | |||||||
| AIP | 5 | 1 | AH receptor-interacting protein | |||||||
| AK1 | 5 | 5 | Adenylate kinase isoenzyme 1 | |||||||
| AK2 | 1 | 3 | Adenylate kinase 2, mitochondrial | |||||||
| AK3 | 5 | GTP:AMP phosphotransferase AK3, mitochondrial | ||||||||
| AK4 | 5 | 2 | 4 | Adenylate kinase 4, mitochondrial | ||||||
| AKAP1 | 4 | A-kinase anchor protein 1, mitochondrial | ||||||||
| AKAP10 | 3 | 2 | A-kinase anchor protein 10, mitochondrial | |||||||
| AKAP12 | 3 | 5 | 3 | A-kinase anchor protein 12 | ||||||
| AKAP13 | 5 | A-kinase anchor protein 13 | ||||||||
| AKAP2 | 1 | 3 | 2 | A-kinase anchor protein 2 | ||||||
| AKAP3 | A-kinase anchor protein 3 | |||||||||
| AKAP4 | A-kinase anchor protein 4 | |||||||||
| AKAP7 | A-kinase anchor protein 7 | |||||||||
| AKR1A1 | 5 | 5 | 1 | Alcohol dehydrogenase [NADP(+)] | ||||||
| AKR1B1 | 5 | 5 | 4 | Aldose reductase | ||||||
| AKR1B10 | Aldo-keto reductase family 1 member B10 | |||||||||
| AKR1B15 | Aldo-keto reductase family 1 member B15 | |||||||||
| AKR1C1 | 5 | Aldo-keto reductase family 1 member C1 | ||||||||
| AKR1C2 | Aldo-keto reductase family 1 member C2 | |||||||||
| AKR1C3 | 5 | 5 | Aldo-keto reductase family 1 member C3 | |||||||
| AKR1C4 | Aldo-keto reductase family 1 member C4 | |||||||||
| AKR1D1 | 5 | 3-oxo-5-beta-steroid 4-dehydrogenase | ||||||||
| AKR7A2 | 5 | 5 | 2 | Aflatoxin B1 aldehyde reductase member 2 | ||||||
| AKR7A3 | 5 | Aflatoxin B1 aldehyde reductase member 3 | ||||||||
| AKR7L | Aflatoxin B1 aldehyde reductase member 4 | |||||||||
| AKT1 | 5 | 3 | 1 | RAC-alpha serine/threonine-protein kinase | ||||||
| AKT2 | 5 | 1 | 1 | RAC-beta serine/threonine-protein kinase | ||||||
| AKT3 | RAC-gamma serine/threonine-protein kinase | |||||||||
| AKTIP | 5 | AKT-interacting protein | ||||||||
| ALAD | 5 | Delta-aminolevulinic acid dehydratase | ||||||||
| ALB | Serum albumin | |||||||||
| ALCAM | 5 | 1 | 3 | CD166 antigen | ||||||
| ALDH16A1 | 5 | 4 | Aldehyde dehydrogenase family 16 member A1 | |||||||
| ALDH18A1 | 4 | 3 | 1 | Delta-1-pyrroline-5-carboxylate synthase | ||||||
| ALDH1A1 | 5 | 5 | 2 | Retinal dehydrogenase 1 | ||||||
| ALDH1A2 | 5 | 1 | Retinal dehydrogenase 2 | |||||||
| ALDH1A3 | 5 | 1 | 3 | Aldehyde dehydrogenase family 1 member A3 | ||||||
| ALDH1B1 | 4 | 3 | Aldehyde dehydrogenase X, mitochondrial | |||||||
| ALDH1L1 | 5 | 2 | Cytosolic 10-formyltetrahydrofolate dehydrogenase | |||||||
| ALDH1L2 | 1 | Mitochondrial 10-formyltetrahydrofolate dehydrogenase | ||||||||
| ALDH2 | 5 | 1 | Aldehyde dehydrogenase, mitochondrial | |||||||
| ALDH3A1 | 2 | Aldehyde dehydrogenase, dimeric NADP-preferring | ||||||||
| ALDH3A2 | 5 | 2 | 1 | Fatty aldehyde dehydrogenase | ||||||
| ALDH3B1 | 5 | 1 | Aldehyde dehydrogenase family 3 member B1 | |||||||
| ALDH3B2 | Aldehyde dehydrogenase family 3 member B2 | |||||||||
| ALDH4A1 | 5 | 5 | 1 | Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial | ||||||
| ALDH5A1 | 5 | Succinate-semialdehyde dehydrogenase, mitochondrial | ||||||||
| ALDH6A1 | 5 | 5 | 2 | Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial | ||||||
| ALDH7A1 | 5 | 5 | Alpha-aminoadipic semialdehyde dehydrogenase | |||||||
| ALDH8A1 | 5 | Aldehyde dehydrogenase family 8 member A1 | ||||||||
| ALDH9A1 | 5 | 3 | 2 | 4-trimethylaminobutyraldehyde dehydrogenase | ||||||
| ALDOA | 5 | 5 | 1 | Fructose-bisphosphate aldolase A | ||||||
| ALDOB | Fructose-bisphosphate aldolase B | |||||||||
| ALDOC | 5 | 5 | 3 | Fructose-bisphosphate aldolase C | ||||||
| ALG13 | 5 | Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 | ||||||||
| ALG2 | 5 | Alpha-1,3/1,6-mannosyltransferase ALG2 | ||||||||
| ALG5 | 5 | Dolichyl-phosphate beta-glucosyltransferase | ||||||||
| ALMS1 | Alstrom syndrome protein 1 | |||||||||
| ALOX12 | Arachidonate 12-lipoxygenase, 12S-type | |||||||||
| ALOX12B | Arachidonate 12-lipoxygenase, 12R-type | |||||||||
| ALOX15 | Arachidonate 15-lipoxygenase | |||||||||
| ALOX15B | Arachidonate 15-lipoxygenase B | |||||||||
| ALOX5 | Arachidonate 5-lipoxygenase | |||||||||
| ALOX5AP | Arachidonate 5-lipoxygenase-activating protein | |||||||||
| ALOXE3 | Hydroperoxide isomerase ALOXE3 | |||||||||
| ALPI | Intestinal-type alkaline phosphatase | |||||||||
| ALPL | 3 | 2 | Alkaline phosphatase, tissue-nonspecific isozyme | |||||||
| ALPP | Alkaline phosphatase, placental type | |||||||||
| ALPPL2 | 3 | Alkaline phosphatase, placental-like | ||||||||
| ALYREF | 5 | THO complex subunit 4 | ||||||||
| AMACR | 5 | Alpha-methylacyl-CoA racemase | ||||||||
| AMBP | Protein AMBP | |||||||||
| AMD1 | S-adenosylmethionine decarboxylase proenzyme | |||||||||
| AMDHD2 | Putative N-acetylglucosamine-6-phosphate deacetylase | |||||||||
| AMICA1 | Junctional adhesion molecule-like | |||||||||
| AMIGO2 | Amphoterin-induced protein 2 | |||||||||
| AMN | Protein amnionless | |||||||||
| AMOTL1 | Angiomotin-like protein 1 | |||||||||
| AMPD1 | AMP deaminase 1 | |||||||||
| AMPD2 | 5 | 4 | AMP deaminase 2 | |||||||
| AMPD3 | 4 | AMP deaminase 3 | ||||||||
| AMPH | Amphiphysin | |||||||||
| AMT | Aminomethyltransferase, mitochondrial | |||||||||
| AMY1A | Alpha-amylase 1 | |||||||||
| AMY2A | Pancreatic alpha-amylase | |||||||||
| AMY2B | Alpha-amylase 2B | |||||||||
| ANG | 5 | Angiogenin | ||||||||
| ANGPT1 | Angiopoietin-1 | |||||||||
| ANGPTL1 | Angiopoietin-related protein 1 | |||||||||
| ANGPTL2 | Angiopoietin-related protein 2 | |||||||||
| ANGPTL3 | Angiopoietin-related protein 3 | |||||||||
| ANGPTL4 | Angiopoietin-related protein 4 | |||||||||
| ANGPTL6 | Angiopoietin-related protein 6 | |||||||||
| ANGPTL7 | Angiopoietin-related protein 7 | |||||||||
| ANK1 | Ankyrin-1 | |||||||||
| ANK2 | Ankyrin-2 | |||||||||
| ANK3 | 5 | 2 | 1 | Ankyrin-3 | ||||||
| ANKFY1 | 3 | 4 | 2 | Rabankyrin-5 | ||||||
| ANKH | 4 | Progressive ankylosis protein homolog | ||||||||
| ANKHD1 | 5 | Ankyrin repeat and KH domain-containing protein 1 | ||||||||
| ANKIB1 | 2 | 4 | Ankyrin repeat and IBR domain-containing protein 1 | |||||||
| ANKMY2 | Ankyrin repeat and MYND domain-containing protein 2 | |||||||||
| ANKRD13A | 5 | 1 | Ankyrin repeat domain-containing protein 13A | |||||||
| ANKRD2 | Ankyrin repeat domain-containing protein 2 | |||||||||
| ANKRD22 | Ankyrin repeat domain-containing protein 22 | |||||||||
| ANKRD28 | 5 | 4 | Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A | |||||||
| ANKRD35 | Ankyrin repeat domain-containing protein 35 | |||||||||
| ANKRD44 | Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B | |||||||||
| ANKS1A | 5 | 4 | Ankyrin repeat and SAM domain-containing protein 1A | |||||||
| ANKS4B | Ankyrin repeat and SAM domain-containing protein 4B | |||||||||
| ANO1 | 3 | 2 | Anoctamin-1 | |||||||
| ANO10 | 5 | Anoctamin-10 | ||||||||
| ANO6 | 4 | 3 | Anoctamin-6 | |||||||
| ANO7 | Anoctamin-7 | |||||||||
| ANP32A | 4 | 5 | Acidic leucine-rich nuclear phosphoprotein 32 family member A | |||||||
| ANP32B | 5 | 3 | Acidic leucine-rich nuclear phosphoprotein 32 family member B | |||||||
| ANP32C | Acidic leucine-rich nuclear phosphoprotein 32 family member C | |||||||||
| ANP32D | Acidic leucine-rich nuclear phosphoprotein 32 family member D | |||||||||
| ANP32E | 5 | 4 | Acidic leucine-rich nuclear phosphoprotein 32 family member E | |||||||
| ANPEP | 5 | 2 | Aminopeptidase N | |||||||
| ANTXR1 | 2 | 4 | 1 | Anthrax toxin receptor 1 | ||||||
| ANTXR2 | 4 | 1 | 2 | Anthrax toxin receptor 2 | ||||||
| ANXA1 | 5 | 3 | 3 | Annexin A1 | ||||||
| ANXA10 | Annexin A10 | |||||||||
| ANXA11 | 5 | 1 | 4 | Annexin A11 | ||||||
| ANXA13 | Annexin A13 | |||||||||
| ANXA2 | 4 | 5 | Annexin A2 | |||||||
| ANXA2P2 | Putative annexin A2-like protein | |||||||||
| ANXA3 | 5 | 5 | 2 | Annexin A3 | ||||||
| ANXA4 | 5 | 5 | 3 | Annexin A4 | ||||||
| ANXA5 | 5 | 4 | 4 | Annexin A5 | ||||||
| ANXA6 | 4 | 4 | Annexin A6 | |||||||
| ANXA7 | 5 | 1 | 1 | Annexin A7 | ||||||
| ANXA8 | 5 | 4 | Annexin A8 | |||||||
| ANXA8L1 | Annexin A8-like protein 1 | |||||||||
| ANXA8L2 | Annexin A8-like protein 2 | |||||||||
| ANXA9 | Annexin A9 | |||||||||
| AOC1 | 1 | Amiloride-sensitive amine oxidase [copper-containing] | ||||||||
| AOC3 | Membrane primary amine oxidase | |||||||||
| AOX1 | Aldehyde oxidase | |||||||||
| AP1B1 | 5 | 5 | AP-1 complex subunit beta-1 | |||||||
| AP1G1 | 5 | 4 | AP-1 complex subunit gamma-1 | |||||||
| AP1G2 | 5 | AP-1 complex subunit gamma-like 2 | ||||||||
| AP1M1 | 5 | 2 | 3 | AP-1 complex subunit mu-1 | ||||||
| AP1M2 | 5 | 5 | 1 | AP-1 complex subunit mu-2 | ||||||
| AP1S1 | 5 | AP-1 complex subunit sigma-1A | ||||||||
| AP2A1 | 5 | 5 | 3 | AP-2 complex subunit alpha-1 | ||||||
| AP2A2 | 4 | 4 | 3 | AP-2 complex subunit alpha-2 | ||||||
| AP2B1 | 5 | 2 | 1 | AP-2 complex subunit beta | ||||||
| AP2M1 | 5 | 5 | AP-2 complex subunit mu | |||||||
| AP3B1 | 5 | 1 | AP-3 complex subunit beta-1 | |||||||
| AP3B2 | AP-3 complex subunit beta-2 | |||||||||
| AP3D1 | 5 | 4 | 3 | AP-3 complex subunit delta-1 | ||||||
| AP3M1 | 5 | 1 | AP-3 complex subunit mu-1 | |||||||
| AP3M2 | AP-3 complex subunit mu-2 | |||||||||
| AP3S1 | 1 | 2 | AP-3 complex subunit sigma-1 | |||||||
| AP5Z1 | AP-5 complex subunit zeta-1 | |||||||||
| APAF1 | 4 | Apoptotic protease-activating factor 1 | ||||||||
| APBB1IP | Amyloid beta A4 precursor protein-binding family B member 1-interacting protein | |||||||||
| APCS | Serum amyloid P-component | |||||||||
| APEH | 1 | 3 | Acylamino-acid-releasing enzyme | |||||||
| APEX1 | 5 | 5 | 4 | DNA-(apurinic or apyrimidinic site) lyase | ||||||
| APH1B | Gamma-secretase subunit APH-1B | |||||||||
| API5 | 4 | 2 | Apoptosis inhibitor 5 | |||||||
| APLP1 | Amyloid-like protein 1 | |||||||||
| APLP2 | 5 | 1 | 4 | Amyloid-like protein 2 | ||||||
| APMAP | 5 | 5 | 1 | Adipocyte plasma membrane-associated protein | ||||||
| APOA1 | 3 | Apolipoprotein A-I | ||||||||
| APOA1BP | 4 | 4 | 4 | NAD(P)H-hydrate epimerase | ||||||
| APOA2 | 4 | 1 | Apolipoprotein A-II | |||||||
| APOA4 | Apolipoprotein A-IV | |||||||||
| APOA5 | Apolipoprotein A-V | |||||||||
| APOB | 4 | 2 | Apolipoprotein B-100 | |||||||
| APOBEC3A | DNA dC->dU-editing enzyme APOBEC-3A | |||||||||
| APOBEC3B | 5 | 5 | DNA dC->dU-editing enzyme APOBEC-3B | |||||||
| APOBEC3C | 5 | 5 | DNA dC->dU-editing enzyme APOBEC-3C | |||||||
| APOBR | Apolipoprotein B receptor | |||||||||
| APOC1 | Apolipoprotein C-I | |||||||||
| APOC2 | Apolipoprotein C-II | |||||||||
| APOC3 | Apolipoprotein C-III | |||||||||
| APOD | 3 | Apolipoprotein D | ||||||||
| APOE | 3 | 1 | Apolipoprotein E | |||||||
| APOF | Apolipoprotein F | |||||||||
| APOH | 3 | Beta-2-glycoprotein 1 | ||||||||
| APOL1 | Apolipoprotein L1 | |||||||||
| APOL2 | 5 | Apolipoprotein L2 | ||||||||
1 - Tissue proteomics data is represented by combined data from two previously published and publicly available datasets.
Prostate cancer multiparametric magnetic resonance imaging visibility is a tumor-intrinsic phenomena
Khoo A, Liu LY, Sadun TY, Salmasi A, Pooli A, Felker E, Houlahan KE, Ignatchenko V, Raman SS, Sisk AE Jr, Reiter RE, Boutros PC, Kislinger T.
J Hematol Oncol. 2022 May 3;15(1):48. doi: 10.1186/s13045-022-01268-6. PMID: 35505417
Prostate cancer multiparametric magnetic resonance imaging visibility is a tumor-intrinsic phenomena
Khoo A, Liu LY, Sadun TY, Salmasi A, Pooli A, Felker E, Houlahan KE, Ignatchenko V, Raman SS, Sisk AE Jr, Reiter RE, Boutros PC, Kislinger T.
J Hematol Oncol. 2022 May 3;15(1):48. doi: 10.1186/s13045-022-01268-6. PMID: 35505417
The Proteogenomic Landscape of Curable Prostate Cancer
Sinha A, Huang V, Livingstone J, Wang J, Fox NS, Kurganovs N, Ignatchenko V, Fritsch K, Donmez N, Heisler LE, Shiah YJ, Yao CQ, Alfaro JA, Volik S, Lapuk A, Fraser M, Kron K, Murison A, Lupien M, Sahinalp C, Collins CC, Tetu B, Masoomian M, Berman DM, van der Kwast T, Bristow RG, Kislinger T, Boutros PC.
Cancer Cell. 2019 Mar 18;35(3):414-427.e6. doi: 10.1016/j.ccell.2019.02.005. PMID: 30889379
Sinha A, Huang V, Livingstone J, Wang J, Fox NS, Kurganovs N, Ignatchenko V, Fritsch K, Donmez N, Heisler LE, Shiah YJ, Yao CQ, Alfaro JA, Volik S, Lapuk A, Fraser M, Kron K, Murison A, Lupien M, Sahinalp C, Collins CC, Tetu B, Masoomian M, Berman DM, van der Kwast T, Bristow RG, Kislinger T, Boutros PC.
Cancer Cell. 2019 Mar 18;35(3):414-427.e6. doi: 10.1016/j.ccell.2019.02.005. PMID: 30889379